title: What is good for the circulation also lessens cancer risk.
authors.affiliation: Department of Medicine, Groote Schuur Hospital and Hatter Institute for Cardiovascular Research in Africa, Observatory, Cape Town, South Africa lionel.opie@uct.ac.za.
authors.forename: Lionel H
authors.initials: LH
authors.lastname: Opie
authors.affiliation: Cardiovascular Research Centre, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Gary D
authors.initials: GD
authors.lastname: Lopaschuk
mesh_terms: D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000150:complications / Q000401:mortality / Q000517:prevention & control*; D004812:Epidemiologic Methods; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009369:Neoplasms / Q000150:complications / Q000401:mortality / Q000517:prevention & control*; D012307:Risk Factors; D040242:Risk Reduction Behavior
chemical_list: D016588:Anticarcinogenic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D001241:Aspirin